Innovative Field Applications of Probiotics, Prebiotics, and Medicinal Plant Products for Disease Control in Aquaculture
4 affiliations
- 1Department of Fisheries and Diseases, Faculty of Veterinary Medicine Aksaray University Aksaray Türkiye
- 2Department of Veterinary Parasitology, Faculty of Veterinary Medicine Aksaray University Aksaray Türkiye
- 3Department of Aquaculture, Faculty of Fisheries Cukurova University Adana Türkiye
- 4Department of Fisheries and Diseases, Graduate School of Health Sciences Aksaray University Aksaray Türkiye
Abstract
Disease outbreaks and the associated reliance on antibiotics pose major constraints to the sustainability of modern aquaculture. As regulatory pressures increase and consumer demand shifts toward residue-free production, diverse biological interventions are gaining prominence as viable alternatives to chemotherapeutics. These include microbiome-modulating agents (probiotics, classical prebiotics, and synbiotics), alongside a distinctly separate category of functional additives: phytogenics (medicinal plant derivatives), which are valued for their direct bioactive and immunomodulatory properties. This review synthesizes current laboratory and field-based evidence regarding the efficacy, mechanisms, and practical challenges of these functional additives. While in vitro and controlled studies demonstrate clear benefits in immune modulation, competitive exclusion, and gut health, real-world application is frequently hindered by environmental inconsistencies and formulation instability. We critically evaluate the impact of system-specific variables and draw several specific mechanistic inferences: First, the over-reliance on static in vitro assays fundamentally fails to predict in vivo colonization under multifactorial field stress (e.g., thermal and pH fluctuations). Second, thermal degradation during industrial feed extrusion is a primary driver of batch-to-batch inconsistency, rendering advanced microencapsulation and post-coating techniques practically mandatory for viable delivery. Third, the efficacy of functional additives is strictly governed by the culture matrix; while the chemical stability of Recirculating Aquaculture Systems (RAS) yields predictable outcomes, open ponds face severe abiotic fluctuations, and Biofloc Technology (BFT) requires precise Carbon-to-Nitrogen (C:N) stoichiometry to facilitate heterotrophic assimilation. To overcome these limitations, we propose a strategic shift toward next-generation interventions specifically thermal-stable postbiotics, precision phage therapy for niche-clearing, and rigorous multi-omics technologies for molecular validation, replacing purely phenotypic observations. By integrating these specific innovations within a precision digital health framework, this work provides a comprehensive roadmap for standardizing bio-based disease control for sustainable and reproducible aquaculture production.
Related
- The microbiome bottleneck in seahorse aquaculture: a conceptual framework linking biofilm ecology, probiotics and larval survival
- Recent advancements on innovative technologies and applications for non-destructive monitoring of tomato quality
- Role and applications of plant essential oils in aquaculture
- Innovative PVD Zr–Ti–Ag Thin-Film Metallic Glasses for Dental Applications: Effect of the Silver Content on Antibacterial and Biocompatible Behaviors
- In vitro assessment of Sargassum platycarpum extract as a novel antimicrobial agent and functional prebiotics
BibTeX
@article{oz2026innovative,
title = {{Innovative Field Applications of Probiotics, Prebiotics, and Medicinal Plant Products for Disease Control in Aquaculture}},
author = {Mustafa Öz and Enes Üstüner and Sümmani Cifci and Suat Dikel and Emin İleri and Furkan Budak},
journal = {Journal of Fish Diseases},
year = {2026},
month = jun,
doi = {10.1111/jfd.70227},
url = {https://doi.org/10.1111/jfd.70227},
note = {CC BY},
}
RIS
TY - JOUR
TI - Innovative Field Applications of Probiotics, Prebiotics, and Medicinal Plant Products for Disease Control in Aquaculture
AU - Mustafa Öz
AU - Enes Üstüner
AU - Sümmani Cifci
AU - Suat Dikel
AU - Emin İleri
AU - Furkan Budak
PY - 2026
DA - 2026/06/26
JO - Journal of Fish Diseases
DO - 10.1111/jfd.70227
UR - https://doi.org/10.1111/jfd.70227
AB - Disease outbreaks and the associated reliance on antibiotics pose major constraints to the sustainability of modern aquaculture. As regulatory pressures increase and consumer demand shifts toward residue-free production, diverse biological interventions are gaining prominence as viable alternatives to chemotherapeutics. These include microbiome-modulating agents (probiotics, classical prebiotics, and synbiotics), alongside a distinctly separate category of functional additives: phytogenics (medicinal plant derivatives), which are valued for their direct bioactive and immunomodulatory properties. This review synthesizes current laboratory and field-based evidence regarding the efficacy, mechanisms, and practical challenges of these functional additives. While in vitro and controlled studies demonstrate clear benefits in immune modulation, competitive exclusion, and gut health, real-world application is frequently hindered by environmental inconsistencies and formulation instability. We critically evaluate the impact of system-specific variables and draw several specific mechanistic inferences: First, the over-reliance on static in vitro assays fundamentally fails to predict in vivo colonization under multifactorial field stress (e.g., thermal and pH fluctuations). Second, thermal degradation during industrial feed extrusion is a primary driver of batch-to-batch inconsistency, rendering advanced microencapsulation and post-coating techniques practically mandatory for viable delivery. Third, the efficacy of functional additives is strictly governed by the culture matrix; while the chemical stability of Recirculating Aquaculture Systems (RAS) yields predictable outcomes, open ponds face severe abiotic fluctuations, and Biofloc Technology (BFT) requires precise Carbon-to-Nitrogen (C:N) stoichiometry to facilitate heterotrophic assimilation. To overcome these limitations, we propose a strategic shift toward next-generation interventions specifically thermal-stable postbiotics, precision phage therapy for niche-clearing, and rigorous multi-omics technologies for molecular validation, replacing purely phenotypic observations. By integrating these specific innovations within a precision digital health framework, this work provides a comprehensive roadmap for standardizing bio-based disease control for sustainable and reproducible aquaculture production.
SN - 0140-7775
SN - 1365-2761
ER -